$Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction$

Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction

Despite modern advances in performing percutaneous coronary interventions, refractory no-reflow remains a serious problem that worsens in-hospital and long-term prognosis. Low-dose adrenaline may exhibit potent beta-receptor agonist properties that mediate coronary vasodilation.Aim. To evaluate the...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. V. Dil, E. V. Vyshlov, V. V. Ryabov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2022-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	st-segment elevation myocardial infarction percutaneous coronary intervention no-reflow phenomenon
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2936
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interleukin-34 as a Robust Predictor of No-Reflow Phenomenon in ST-Elevation Myocardial Infarction: Insights into Inflammatory Mechanisms and Clinical Implications
by: Mehdi Karasu, et al.
Published: (2024-10-01)

«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction
by: V.І. Tseluyko, et al.
Published: (2018-09-01)

Clinical, laboratory, and procedural predictors of slow flow/no reflow phenomenon after emergency percutaneous coronary interventions in ST-elevated myocardial infarction
by: Fatemeh Bamarinejad, et al.
Published: (2024-11-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Prognostic value of no-reflow phenomenon in myocardial infarction: the role of the severity of ischemic damage
by: A. A. Frolov, et al.
Published: (2025-01-01)

Delayed endovascular surgery in patients with acute ST-segment elevation myocardial infarction due to massive culprit arterial thrombosis in the prevention of slow/no-reflow phenomenon
by: A. V. Azarov, et al.
Published: (2021-09-01)

PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01)

Phenotypes of coronary microvascular obstruction phenomenon (no-reflow) during percutaneous coronary interventions in myocardial infarction
by: A. A. Frolov, et al.
Published: (2024-01-01)

The no-reflow phenomenon: current treatment and prevention strategies
by: S. V. Dil, et al.
Published: (2025-04-01)

No-reflow phenomenon and reperfusion injury. Mechanisms and treatment
by: M. Yu. Gilyarov, et al.
Published: (2022-03-01)

Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction
by: A. V. Azarov, et al.
Published: (2021-03-01)

Predictors of the no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction due to stenotic coronary artery disease
by: O. O. Khaniukov, et al.
Published: (2025-04-01)

NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01)

Primary percutaneous intervention of the right coronary artery in a setting of anomalous origination of left coronary artery from the opposite sinus of Valsalva
by: Babić Rade, et al.
Published: (2020-01-01)

Usefulness of platelet mass index in the prediction of angiographic no-reflow in patients with acute ST-segment elevation myocardial infarction
by: Erdoğan Sökmen, et al.
Published: (2025-05-01)

Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
by: E. V. Konstantinova, et al.
Published: (2024-03-01)

Thrombus aspiration in patients with ST-segment elevation myocardial infarction: a literature review
by: V. V. Ryabov, et al.
Published: (2023-09-01)

Which сlinical, laboratory, and instrumental factors are associated with the development of the no-reflow phenomenon in patients with acute coronary syndrome?
by: E. V. Konstantinova, et al.
Published: (2025-08-01)

Thrombolysis for Prevention of Cerebral No-Reflow After Cardiopulmonary Resuscitation
by: K. -A. Hossmann, et al.
Published: (2009-04-01)

Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study
by: Ahmed Darwish, et al.
Published: (2022-03-01)

Improving “No‐Reflow” After Complete Reperfusion: The Role of Intravenous Thrombolysis in Vertebrobasilar Artery Occlusion Patients Undergoing Endovascular Treatment
by: Zhanglin Li, et al.
Published: (2025-08-01)

Correlations between morphological features of intracoronary thrombi and left ventricular structure and function in patients with ST-segment elevation myocardial infarction
by: D. D. Zerbino, et al.
Published: (2020-10-01)

The impact of alpha lipoic acid administration on oxidative stress markers and occurrence of no-reflow phenomenon in post myocardial infarction patients
by: Omar R. Elsayed, et al.
Published: (2025-05-01)

CORONARY MICROVASCULAR OBSTRUCTION PHENOMENON AFTER ENDOVASCULAR RECANALIZATION IN PATIENTS WITH CHRONIC CORONARY OCCLUSIONS
by: N. A. Yaitsky, et al.
Published: (2018-01-01)

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM
by: N. S. Kostritca, et al.
Published: (2024-07-01)

THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION)
by: V. A. Sulimov
Published: (2015-09-01)

Myocardial ischemia – reperfusion injury
by: S. V. Salo, et al.
Published: (2023-10-01)

Research progress on coronary slow flow or no-reflow of coronary heart disease undergoing percutaneous coronary intervention surgery
by: Mengdi Wang, et al.
Published: (2025-01-01)

The predictive value of uric acid/albumin ratio for no-reflow/slow-flow in patients after PCI for acute non-ST segment elevation myocardial infarction
by: GONG Junrong, LI Yafei, DAI He, ZHU Fuyu, CHEN Wenting
Published: (2025-02-01)

The feasibility of Kimny guiding catheter for ST-segment elevation myocardial infarction
by: Sou-Chan Tsai, et al.
Published: (2022-01-01)

Clinical features of the acute period of myocardial infarction with ST segment elevation in patients after reperfusion therapy
by: S. M. Kyselov, et al.
Published: (2020-10-01)

Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon
by: Hubert Borzuta, et al.
Published: (2025-07-01)

THE RESULTS OF DELAYED ENDOVASCULAR INTERVENTION IN ST ELEVATION ACUTE MYOCARDIAL INFARCTION DUE TO THROMBOTIC OCCLUSION OF CORONARY ARTERY
by: A. V. Azarov, et al.
Published: (2017-02-01)

Prediction of in-hospital mortality in patients with ST-segment elevation acute myocardial infarction after percutaneous coronary intervention
by: B. I. Geltser, et al.
Published: (2023-07-01)

Heart rate variability in patients with acute ST-segment elevation myocardial infarction after COVID-19
by: V. P. Mikhin, et al.
Published: (2023-11-01)

The Impact of Baseplate Bow on Vacuum Reflow Soldering
by: 曾雄, et al.
Published: (2011-01-01)

Factors influencing no-reflow phenomenon in patients with ST-segment myocardial infarction treated with primary percutaneous coronary intervention
by: Đenić Nemanja, et al.
Published: (2018-01-01)

Retrospective analysis of outcomes in patients with myocardial infarction in late admission to PCI center
by: S. A. Vorontsova, et al.
Published: (2023-07-01)

Effect of late culprit coronary artery revascularization on prognosis of patients with ST-elevation myocardial infarction
by: A. A. Frolov, et al.
Published: (2020-09-01)